BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37073890)

  • 21. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
    Seto DN; Kandarian SC; Jackman RW
    J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?
    Jaśkiewicz A; Domoradzki T; Pająk B
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
    White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Jianpi Decoction Combined with Medroxyprogesterone Acetate Alleviates Cancer Cachexia and Prevents Muscle Atrophy by Directly Inhibiting E3 Ubiquitin Ligase.
    Li Q; Kong ZD; Wang H; Gu HH; Chen Z; Li SG; Chen YQ; Cai Y; Yang ZJ
    Chin J Integr Med; 2024 Jun; 30(6):499-506. PubMed ID: 37612478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paeoniflorin alleviated muscle atrophy in cancer cachexia through inhibiting TLR4/NF-κB signaling and activating AKT/mTOR signaling.
    Zhu Z; Li C; Gu X; Wang X; Zhang G; Fan M; Zhao Y; Liu X; Zhang X
    Toxicol Appl Pharmacol; 2024 Mar; 484():116846. PubMed ID: 38331105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β‑carotene attenuates muscle wasting in cancer cachexia by regulating myogenesis and muscle atrophy.
    Kim Y; Oh Y; Kim YS; Shin JH; Lee YS; Kim Y
    Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
    Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
    Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy.
    Kim HJ; Lee JH; Kim SW; Lee SH; Jung DW; Williams DR
    PLoS One; 2021; 16(5):e0252135. PubMed ID: 34038481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway.
    Hu W; Ru Z; Zhou Y; Xiao W; Sun R; Zhang S; Gao Y; Li X; Zhang X; Yang H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1091-1102. PubMed ID: 31002945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.
    Gu X; Lu S; Fan M; Xu S; Lin G; Zhao Y; Zhao W; Liu X; Dong X; Zhang X
    Eur J Pharmacol; 2024 Jul; 974():176538. PubMed ID: 38552940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):975-988. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnosol analogue WK-63 alleviated cancer cachexia by inhibiting NF-κB and activating AKT pathways in muscle while inhibiting NF-κB and AMPK pathways in adipocyte.
    Pan X; Zhang G; Wei K; Gu X; Dan J; Zhao Y; Liu X; Cheng C; Zhang X
    Toxicol Appl Pharmacol; 2023 Nov; 479():116729. PubMed ID: 37863360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
    Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
    Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia.
    Shukla SK; Markov SD; Attri KS; Vernucci E; King RJ; Dasgupta A; Grandgenett PM; Hollingsworth MA; Singh PK; Yu F; Mehla K
    Cancer Lett; 2020 Aug; 484():29-39. PubMed ID: 32344015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myostatin is a novel tumoral factor that induces cancer cachexia.
    Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
    Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signaling pathways perturbing muscle mass.
    Glass DJ
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Babao Dan Alleviates Cancer Cachexia in Mice Via Inhibiting IL-6/STAT3 Signaling Pathway.
    Qiu Z; Wo D; Zhong X; Chen J; Ma E; He J; Peng J; Zhu W; Ren DN
    Integr Cancer Ther; 2023; 22():15347354231168369. PubMed ID: 37077153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.